肺がん治療薬の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21APR3495)
◆英語タイトル:Global Lung Cancer Treatment Drugs Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR3495
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月
◆ページ数:92
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥526,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥789,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、肺がん治療薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(化学療法、標的療法、パイプライン薬)、用途別市場規模(病院、研究所、診断センター、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・肺がん治療薬の市場動向
・企業の競争状況、市場シェア
・肺がん治療薬の種類別市場規模(化学療法、標的療法、パイプライン薬)
・肺がん治療薬の用途別市場規模(病院、研究所、診断センター、その他)
・肺がん治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・肺がん治療薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・肺がん治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・肺がん治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・肺がん治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Roche、AstraZeneca、Eli Lilly and Company、Sanofi-Aventis、Pfizer、GlaxoSmithKline)
・結論
【レポートの概要】

Lung Cancer Treatment Drugs are durgs used to cure lung cancer.
In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing lung cancer are driving the growth of the global lung cancer market.

Market Analysis and Insights: Global Lung Cancer Treatment Drugs Market
The global Lung Cancer Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lung Cancer Treatment Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lung Cancer Treatment Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lung Cancer Treatment Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lung Cancer Treatment Drugs market.

Global Lung Cancer Treatment Drugs Scope and Market Size
Lung Cancer Treatment Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lung Cancer Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Targeted Therapies
Pipeline Drugs

Segment by Application
Hospitals
Research Institutes
Diagnostic Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
AstraZeneca
Eli Lilly and Company
Sanofi-Aventis
Pfizer
GlaxoSmithKline

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Treatment Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Targeted Therapies
1.2.4 Pipeline Drugs
1.3 Market by Application
1.3.1 Global Lung Cancer Treatment Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Research Institutes
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Lung Cancer Treatment Drugs Market Perspective (2016-2027)
2.2 Lung Cancer Treatment Drugs Growth Trends by Regions
2.2.1 Lung Cancer Treatment Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lung Cancer Treatment Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Lung Cancer Treatment Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Lung Cancer Treatment Drugs Industry Dynamic
2.3.1 Lung Cancer Treatment Drugs Market Trends
2.3.2 Lung Cancer Treatment Drugs Market Drivers
2.3.3 Lung Cancer Treatment Drugs Market Challenges
2.3.4 Lung Cancer Treatment Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Treatment Drugs Players by Revenue
3.1.1 Global Top Lung Cancer Treatment Drugs Players by Revenue (2016-2021)
3.1.2 Global Lung Cancer Treatment Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Lung Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lung Cancer Treatment Drugs Revenue
3.4 Global Lung Cancer Treatment Drugs Market Concentration Ratio
3.4.1 Global Lung Cancer Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Treatment Drugs Revenue in 2020
3.5 Lung Cancer Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Lung Cancer Treatment Drugs Product Solution and Service
3.7 Date of Enter into Lung Cancer Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Treatment Drugs Breakdown Data by Type
4.1 Global Lung Cancer Treatment Drugs Historic Market Size by Type (2016-2021)
4.2 Global Lung Cancer Treatment Drugs Forecasted Market Size by Type (2022-2027)

5 Lung Cancer Treatment Drugs Breakdown Data by Application
5.1 Global Lung Cancer Treatment Drugs Historic Market Size by Application (2016-2021)
5.2 Global Lung Cancer Treatment Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Lung Cancer Treatment Drugs Market Size (2016-2027)
6.2 North America Lung Cancer Treatment Drugs Market Size by Type
6.2.1 North America Lung Cancer Treatment Drugs Market Size by Type (2016-2021)
6.2.2 North America Lung Cancer Treatment Drugs Market Size by Type (2022-2027)
6.2.3 North America Lung Cancer Treatment Drugs Market Size by Type (2016-2027)
6.3 North America Lung Cancer Treatment Drugs Market Size by Application
6.3.1 North America Lung Cancer Treatment Drugs Market Size by Application (2016-2021)
6.3.2 North America Lung Cancer Treatment Drugs Market Size by Application (2022-2027)
6.3.3 North America Lung Cancer Treatment Drugs Market Size by Application (2016-2027)
6.4 North America Lung Cancer Treatment Drugs Market Size by Country
6.4.1 North America Lung Cancer Treatment Drugs Market Size by Country (2016-2021)
6.4.2 North America Lung Cancer Treatment Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Lung Cancer Treatment Drugs Market Size (2016-2027)
7.2 Europe Lung Cancer Treatment Drugs Market Size by Type
7.2.1 Europe Lung Cancer Treatment Drugs Market Size by Type (2016-2021)
7.2.2 Europe Lung Cancer Treatment Drugs Market Size by Type (2022-2027)
7.2.3 Europe Lung Cancer Treatment Drugs Market Size by Type (2016-2027)
7.3 Europe Lung Cancer Treatment Drugs Market Size by Application
7.3.1 Europe Lung Cancer Treatment Drugs Market Size by Application (2016-2021)
7.3.2 Europe Lung Cancer Treatment Drugs Market Size by Application (2022-2027)
7.3.3 Europe Lung Cancer Treatment Drugs Market Size by Application (2016-2027)
7.4 Europe Lung Cancer Treatment Drugs Market Size by Country
7.4.1 Europe Lung Cancer Treatment Drugs Market Size by Country (2016-2021)
7.4.2 Europe Lung Cancer Treatment Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Treatment Drugs Market Size (2016-2027)
8.2 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Type
8.2.1 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Application
8.3.1 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Region
8.4.1 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lung Cancer Treatment Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Lung Cancer Treatment Drugs Market Size (2016-2027)
9.2 Latin America Lung Cancer Treatment Drugs Market Size by Type
9.2.1 Latin America Lung Cancer Treatment Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Lung Cancer Treatment Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Lung Cancer Treatment Drugs Market Size by Type (2016-2027)
9.3 Latin America Lung Cancer Treatment Drugs Market Size by Application
9.3.1 Latin America Lung Cancer Treatment Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Lung Cancer Treatment Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Lung Cancer Treatment Drugs Market Size by Application (2016-2027)
9.4 Latin America Lung Cancer Treatment Drugs Market Size by Country
9.4.1 Latin America Lung Cancer Treatment Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Lung Cancer Treatment Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Treatment Drugs Market Size (2016-2027)
10.2 Middle East & Africa Lung Cancer Treatment Drugs Market Size by Type
10.2.1 Middle East & Africa Lung Cancer Treatment Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lung Cancer Treatment Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lung Cancer Treatment Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Lung Cancer Treatment Drugs Market Size by Application
10.3.1 Middle East & Africa Lung Cancer Treatment Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lung Cancer Treatment Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lung Cancer Treatment Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Lung Cancer Treatment Drugs Market Size by Country
10.4.1 Middle East & Africa Lung Cancer Treatment Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lung Cancer Treatment Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Lung Cancer Treatment Drugs Introduction
11.1.4 Roche Revenue in Lung Cancer Treatment Drugs Business (2016-2021)
11.1.5 Roche Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Lung Cancer Treatment Drugs Introduction
11.2.4 AstraZeneca Revenue in Lung Cancer Treatment Drugs Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Details
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Lung Cancer Treatment Drugs Introduction
11.3.4 Eli Lilly and Company Revenue in Lung Cancer Treatment Drugs Business (2016-2021)
11.3.5 Eli Lilly and Company Recent Development
11.4 Sanofi-Aventis
11.4.1 Sanofi-Aventis Company Details
11.4.2 Sanofi-Aventis Business Overview
11.4.3 Sanofi-Aventis Lung Cancer Treatment Drugs Introduction
11.4.4 Sanofi-Aventis Revenue in Lung Cancer Treatment Drugs Business (2016-2021)
11.4.5 Sanofi-Aventis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Lung Cancer Treatment Drugs Introduction
11.5.4 Pfizer Revenue in Lung Cancer Treatment Drugs Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Lung Cancer Treatment Drugs Introduction
11.6.4 GlaxoSmithKline Revenue in Lung Cancer Treatment Drugs Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 肺がん治療薬の世界市場規模・現状・予測2021年-2027年(Global Lung Cancer Treatment Drugs Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。